287 related articles for article (PubMed ID: 25238144)
1. An activatable prodrug for the treatment of metastatic tumors.
Kim EJ; Bhuniya S; Lee H; Kim HM; Cheong C; Maiti S; Hong KS; Kim JS
J Am Chem Soc; 2014 Oct; 136(39):13888-94. PubMed ID: 25238144
[TBL] [Abstract][Full Text] [Related]
2. 10-Boronic acid substituted camptothecin as prodrug of SN-38.
Wang L; Xie S; Ma L; Chen Y; Lu W
Eur J Med Chem; 2016 Jun; 116():84-89. PubMed ID: 27060760
[TBL] [Abstract][Full Text] [Related]
3. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy.
Leu YL; Chen CS; Wu YJ; Chern JW
J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465
[TBL] [Abstract][Full Text] [Related]
4. Irinotecan delivery by unimolecular micelles composed of reduction-responsive star-like polymeric prodrug with high drug loading for enhanced cancer therapy.
Gao YE; Bai S; Shi X; Hou M; Ma X; Zhang T; Xiao B; Xue P; Kang Y; Xu Z
Colloids Surf B Biointerfaces; 2018 Oct; 170():488-496. PubMed ID: 29960949
[TBL] [Abstract][Full Text] [Related]
5. An activatable theranostic for targeted cancer therapy and imaging.
Bhuniya S; Maiti S; Kim EJ; Lee H; Sessler JL; Hong KS; Kim JS
Angew Chem Int Ed Engl; 2014 Apr; 53(17):4469-74. PubMed ID: 24644015
[TBL] [Abstract][Full Text] [Related]
6. Cancer Targeted Enzymatic Theranostic Prodrug: Precise Diagnosis and Chemotherapy.
Shin WS; Han J; Verwilst P; Kumar R; Kim JH; Kim JS
Bioconjug Chem; 2016 May; 27(5):1419-26. PubMed ID: 27135737
[TBL] [Abstract][Full Text] [Related]
7. Novel polymeric prodrug with multivalent components for cancer therapy.
Khandare JJ; Chandna P; Wang Y; Pozharov VP; Minko T
J Pharmacol Exp Ther; 2006 Jun; 317(3):929-37. PubMed ID: 16469865
[TBL] [Abstract][Full Text] [Related]
8. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
Wang Z; Wu H; Liu P; Zeng F; Wu S
Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
[TBL] [Abstract][Full Text] [Related]
9. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.
Hu Y; Zeng F
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642
[TBL] [Abstract][Full Text] [Related]
10. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery.
Bai S; Gao YE; Ma X; Shi X; Hou M; Xue P; Kang Y; Xu Z
Carbohydr Polym; 2018 Feb; 182():235-244. PubMed ID: 29279120
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation.
Prijovich ZM; Burnouf PA; Chou HC; Huang PT; Chen KC; Cheng TL; Leu YL; Roffler SR
Mol Pharm; 2016 Apr; 13(4):1242-50. PubMed ID: 26824303
[TBL] [Abstract][Full Text] [Related]
12. Selective cancer therapy by extracellular activation of a highly potent glycosidic duocarmycin analogue.
Chen KC; Schmuck K; Tietze LF; Roffler SR
Mol Pharm; 2013 May; 10(5):1773-82. PubMed ID: 23448264
[TBL] [Abstract][Full Text] [Related]
13. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy.
Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S
Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950
[TBL] [Abstract][Full Text] [Related]
14. Real-time monitoring of etoposide prodrug activated by hydrogen peroxide with improved safety.
Zhu J; Chen J; Song D; Zhang W; Guo J; Cai G; Ren Y; Wan C; Kong L; Yu W
J Mater Chem B; 2019 Dec; 7(47):7548-7557. PubMed ID: 31720667
[TBL] [Abstract][Full Text] [Related]
15. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
16. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.
Schmid B; Chung DE; Warnecke A; Fichtner I; Kratz F
Bioconjug Chem; 2007; 18(3):702-16. PubMed ID: 17378599
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.
Alferiev IS; Iyer R; Croucher JL; Adamo RF; Zhang K; Mangino JL; Kolla V; Fishbein I; Brodeur GM; Levy RJ; Chorny M
Biomaterials; 2015 May; 51():22-29. PubMed ID: 25770994
[TBL] [Abstract][Full Text] [Related]
18. Self-sufficing H2O2-responsive nanocarriers through tumor-specific H2O2 production for synergistic oxidation-chemotherapy.
Li J; Ke W; Wang L; Huang M; Yin W; Zhang P; Chen Q; Ge Z
J Control Release; 2016 Mar; 225():64-74. PubMed ID: 26806789
[TBL] [Abstract][Full Text] [Related]
19. A dithiocarbamate-based H
Pan Q; Zhang B; Peng X; Wan S; Luo K; Gao W; Pu Y; He B
Chem Commun (Camb); 2019 Nov; 55(92):13896-13899. PubMed ID: 31675022
[TBL] [Abstract][Full Text] [Related]
20. A camptothecin-based, albumin-binding prodrug enhances efficacy and safety in vivo.
Cheng Z; Huang Y; Shen Q; Zhao Y; Wang L; Yu J; Lu W
Eur J Med Chem; 2021 Dec; 226():113851. PubMed ID: 34547508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]